Lars Holtug
Director · Ascendis Pharma A/S
IndividualSelling only
- 2026
- Sep 3, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Lars Holtug files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Flemming Steen Jensen - $4.64M in ASND purchases and sales in the last 12 months
- Mads Bodenhoff - $811K in ASND purchases and sales in the last 12 months
- Jean Jacques Bienaime - $699K in ASND purchases and sales in the last 12 months
- Scott Thomas Smith - $78K in ASND purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Lars Holtug?
Lars Holtug is a corporate insider, tracked as Director of Ascendis Pharma A/S (ASND). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Lars Holtug submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Lars Holtug been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($62K) across all tracked filings.
